Myo-inositol is a 6-carbon cyclic polyalcohol also known as meso-inositol, meat sugar, inosite, and i-inositol. It occurs in nature in both free (myo-inositol) and bound (inositol phosphates and phosphatidylinositol) forms. For the determination of free myo-inositol, samples are mixed with dilute hydrochloric acid to extract myo-inositol and precipitate proteins, diluted with water, and filtered. For the determination of myo-inositol bound as phosphatidylinositol, samples are extracted with chloroform, isolated from other fats with silica SPE cartridges, and hydrolyzed with concentrated acid to free myo-inositol. Prepared samples are first injected onto a Dionex CarboPac PA1 column, which separates myo-inositol from other late-eluting carbohydrates. After column switching, myo-inositol is further separated on a CarboPac MA1 column using a 0.12% sodium hydroxide mobile phase; strongly retained carbohydrates are eluted from the PA1 column with a 3% sodium hydroxide mobile phase. Eluant from the CarboPac MA1 analytical column passes through an electrochemical detector cell where myo-inositol is detected by pulsed amperometry using a gold electrode. The method showed appropriate performance characteristics versus selected established standard method performance requirement parameters for the determination of myo-inositol: linear response; repeatability (RSD r ) of 2%; and intermediate precision (RSD ir ) of 2.5%. Instrument LOD and LOQ were 0.0004 and 0.0013 mg/100 mL, respectively, and correspond to a free myo-inositol quantitation limit of 0.026 mg/100 g and a phosphatidylinositol quantitation limit of 0.016 mg/100 g. Correlation with the reference microbiological assay was good. The proposed method has been accepted by the Expert Review Panel as an AOAC First Action Method, suitable for the routine determination of myo-inositol in infant formula and adult nutritionals.
M yo-inositol is a 6-carbon cyclic polyalcohol ( Figure 1 ) that occurs as anhydrous, hydroscopic crystals. Myo-inositol has a sweet taste, is soluble in water, and is slightly soluble in alcohol. It is insoluble in ether and other organic solvents. Aqueous solutions are neutral. It has a molecular weight of 180.16, a melting point of 225-227°C, and is optically inactive.
There are nine possible stereoisomeric forms of inositol. Seven are optically inactive or "meso." Two optically active forms, the racemic form, and several cis, trans-isomers occur naturally. Myo-inositol is the most widely distributed inositol isomer and is present in all living cells. It occurs in nature in both free (myo-inositol) and bound (inositol phosphates and phosphatidylinositol) forms. Fruits, beans, grains, and nuts are all good sources of myo-inositol. Myo-inositol is essential for the growth of many mammalian cells. Although free myo-inositol is not essential for humans, the abnormal metabolism of myo-inositol by the body has been associated with diabetes mellitus and chronic renal failure. The liquid chromatography method with electrochemical (pulsed amperometry) detection (PAD) allows for the quantitation of myo-inositol in infant, pediatric, and adult nutritional formulas. The concentration of myo-inositol is calculated by comparison with standards of known concentration. Total myo-inositol, as defined by AOAC standard method performance requirement (SMPR) 2011.007 (1), can be calculated by adding the free myo-inositol and myo-inositol bound as phosphatidylinositol data.
The method was validated for the quantitation of free myo-inositol only. Repeatability was determined from triplicate analyses performed on the same day. 
D. Preparation of Reagents and Standard Solutions
All solutions can be scaled up or down for convenience provided good laboratory practices are observed. Solutions can be stored at 2-30°C in tight, inert containers otherwise noted. Thoroughly mix or stir products prior to sampling. For liquid products, accurately weigh 0.5 to 5 g (±10%) of product into a 100 mL volumetric flask and record the weight to the nearest 0.0001 g. For powdered products that do not require reconstitution, accurately weigh 0.25 to 1.5 g powder into a 100 mL volumetric flask and record the weight to the nearest 0.0001 g. Add approximately 10 to 15 mL laboratory water to the volumetric and swirl or stir to completely dissolve the powder. For powdered products that are not homogeneous at the subgram level, reconstitute following the product label instructions and accurately weigh 0.5 to 5 g reconstituted product into a 100 mL volumetric flask. Record the weight to the nearest 0.0001 g. Add enough 0.5% hydrochloric acid to each sample to adjust the sample pH to 4.5 ± 0.2 and swirl to mix. Allow the volumetric flasks to set a minimum of 2 min. Dilute to volume with laboratory water and mix well. Filter samples through Whatman 2V filter paper into 125 mL Erlenmeyer flasks. (Note: Although some samples will filter cloudy, the filtrates can still be used.) Filter an aliquot of sample filtrate through a 0.45 µm syringe filter into an autosampler vial. or reconstituted powder product or 1 g (±10%) homogeneous powder into a 50 mL centrifuge tube and record the weight to the nearest 0.0001 g. Add 10 mL methanol and stir for at least 20 min. Add 20 mL chloroform and stir for at least 5 min. If large clumps form when chloroform is added, cap tube and shake well to mix sample. Add 5 mL 6% metaphosphoric acid and 1 mL 1 N NaCl and mix well. Centrifuge. Remove the bottom chloroform layer and evaporate with nitrogen in a 60°C water bath.
(2) Sample cleanup.-Condition a 1 g silica SPE cartridge with 6 mL hexane. Dissolve residue in bottom of centrifuge tube in 1 mL chloroform:methanol (2:1). Quantitatively transfer dissolved residue to the conditioned silica SPE cartridge. Rinse SPE cartridge with 3 mL hexane:diethyl ether (80:20) and discard the eluant. Rinse SPE cartridge with 3 mL hexane:diethyl ether (50:50), 4 mL methanol, and 4 mL methanol:chloroform:water (75:15:10) and collect all eluants in a single 50 mL centrifuge tube. Evaporate eluants collected from SPE cartridge with nitrogen in a 60°C water bath.
(3) Hydrolysis.-Add 40 µL concentrated acetic acid and 2 mL concentrated hydrochloric acid to residue in centrifuge tube from the sample cleanup step. Tightly cap tube. Heat in a 110°C oven for 2 h. Cool. Dilute mixture with approximately 10 mL H 2 O and then add 1.25 mL 50% (w/w) sodium hydroxide. Transfer sample to a 50 mL volumetric flask and dilute to volume with water. Filter an aliquot of sample filtrate through a 0.45 µm syringe filter into an autosampler vial.
(c) HPLC analysis.
- (1) See Tables 2011.18A and B for instrument operating conditions and PAD settings, respectively.
(2) Instrument startup.-The HPLC system should be located in an area where temperature fluctuations will be minimal throughout the run.
Prepare mobile phases. Helium sparge mobile phases and/or pressurize mobile phase reservoirs. If necessary, clean and polish the gold working electrode. Turn on the detector and pump mobile phase over the columns at a flow rate of 0.40 mL/min for at least ½ h to equilibrate the system. Verify that the detector is stable before beginning an analysis. Inject 20 μL of the most concentrated standard at least 5 times and note the peak areas or heights. If the system is equilibrated, the RSD of the peak areas or heights of the last three standard injections should be ≤2.0%.
(3) Standard and sample analysis.-Once the system has equilibrated, inject one standard at each concentration. After a set of standards has been injected, a control sample and up to 14 samples can be injected before another set of standards should be injected.
(4) System shutdown.-After all samples and standards have been analyzed, inject one vial of water to clean out the autosampler needle and tubing. Store the analytical columns in mobile phase [0.12% (30 mM) sodium hydroxide]. Turn off the electrochemical cell. Flush the pump heads with water to remove sodium hydroxide.
F. Calculations
Before calculating myo-inositol concentrations in samples, compare the myo-inositol standard peaks with the myo-inositol sample peaks and confirm that there are not any interfering compounds and that the myo-inositol sample peak areas or heights are within the range of the myo-inositol standard peak areas or heights. See Lactose-free infant formula RTF 3 At each working standard level, the peak areas or heights of standards injected before and after a set of samples must not increase or decrease by more than 7%.
(c) Calculation of myo-inositol in samples and controls.-The concentration of myo-inositol in a prepared sample or control is extrapolated from the standard curve prepared above. From the diluted, prepared sample concentration, the product concentration can be calculated:
where C p is the concentration of myo-inositol in the product sample or control in milligrams per kilogram; C d is the concentration of myo-inositol in the prepared sample or control in milligrams per liter; D 1 is the dilution volume in milliliters; and S is the sample weight in grams.
Total myo-inositol, as defined by AOAC SMPR 2011.007 (1), can be calculated by adding the free myo-inositol and myoinositol bound as phosphatidylinositol data.
Note: For each set of samples, the control result must be within three standard deviations of the control mean.
Reference: J. AOAC Int. 95, (future issue)
Results and Discussion
During validation, the average repeatability was 2.0% RSD and the intermediate precision was 2.5% RSD, as summarized in Tables 1 and 2 . Accuracy was determined by comparison to a reference microbiological assay as detailed in Table 3 (2). The instrument LOD and LOQ of the method were estimated to be 0.0004 and 0.0013 mg/100 mL, respectively, and correspond to a free myo-inositol quantitation limit of 0.026 mg/100 g.
Although this method has not been fully validated for the quantitation of myo-inositol bound as phosphatidylinositol, some data have been generated and are summarized in Table 4 . The phosphatidylinositol quantitation limit has been estimated to be 0.016 mg/100 g.
